Otros idiomas Bio Plus Co., Ltd

Acciones

A099430

KR7099430001

Precio de cierre Korea S.E. Otros sitios de cotización 00:00:00 05/06/2024			Varia. Cinco días.	Varia. 1 de enero.
4.330 ^KRW	-1,48 %		-5,66 %	-36,97 %

24/01	Elevance Health ofrece una previsión de beneficios para 2024 superior a la prevista tras el avance del cuarto trimestre	MT
2023	Elevance Health eleva su previsión de beneficios para todo el año al subir los resultados del tercer trimestre	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Elevance Health Offers Stronger-Than-Expected 2024 Earnings Outlook After Fourth-Quarter Beat	24/01
Elevance Health Issues Upbeat 2024 Adjusted. Earnings Outlook After 4Q Revenue Gains	24/01
Tranche Update on BioPlus Co., Ltd.'s Equity Buyback Plan announced on May 9, 2023.	09/11
Tranche Update on BioPlus Co., Ltd.'s Equity Buyback Plan announced on May 9, 2023.	09/11
BioPlus Co., Ltd.'s Equity Buyback announced on May 9, 2023, has expired with 743,436 shares, representing 1.28% for ¥4,990.07 million.	08/11
Elevance Health Lifts Full-Year Earnings Outlook as Third-Quarter Results Rise	18/10/23
Elevance Health 3Q Revenue Rises on Higher Premiums	18/10/23
BioPlus Acquisition, Avertix Medical Terminate Business Combination Deal	04/10/23
Tranche Update on BioPlus Co., Ltd.'s Equity Buyback Plan announced on May 9, 2023.	09/08/23
BioPlus Co., Ltd. announces an Equity Buyback for KRW 5,000 million worth of its shares.	09/05/23
BioPlus Co., Ltd. authorizes a Buyback Plan.	09/05/23
BioPlus Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23/03/23
Elevance Health to Acquire Specialty Pharmacy BioPlus for Undisclosed Sum	09/11/22
BioPlus to Raise $14.2 Million from Share Sale; Shares Jump 4%	06/10/22
BioPlus Co., Ltd. announced that it expects to receive KRW 19.99996275 billion in funding	06/10/22
Tranche Update on BioPlus Co., Ltd.'s Equity Buyback Plan announced on December 7, 2021.	08/06/22
BioPlus Co., Ltd.'s Equity Buyback announced on December 7, 2021, has expired with 199,320 shares, representing 1.43% for KRW 4,987.71 million.	07/06/22
BioPlus Co., Ltd.'s Equity Buyback announced on October 13, 2021, has expired.	13/04/22
BioPlus Co., Ltd.(KOSDAQ:A099430) added to S&P Global BMI Index	21/03/22
BioPlus Co., Ltd. announces an Equity Buyback for KRW 5,000 million worth of its shares.	07/12/21

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Bio Plus Co., Ltd

Acciones

A099430

KR7099430001

Otros idiomas

Filtros